News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
862,043 Results
Type
Article (87499)
Company Profile (807)
Press Release (773715)
Multimedia
Podcasts (176)
Webinars (28)
Section
Business (233080)
Career Advice (4140)
Deals (39803)
Drug Delivery (138)
Drug Development (91272)
Employer Resources (203)
FDA (18293)
Job Trends (17406)
News (397456)
Policy (39927)
Tag
Academia (3005)
Academic (2)
Accelerated approval (18)
Adcomms (35)
Allergies (127)
Alliances (56980)
ALS (147)
Alzheimer's disease (1688)
Antibody-drug conjugate (ADC) (259)
Approvals (18326)
Artificial intelligence (506)
Autoimmune disease (98)
Automation (29)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (23)
Biosimilars (165)
Biotechnology (485)
Bladder cancer (137)
Brain cancer (53)
Breast cancer (516)
Cancer (4087)
Cardiovascular disease (355)
Career advice (3561)
Career pathing (38)
CAR-T (252)
CDC (57)
Cell therapy (700)
Cervical cancer (33)
Clinical research (75706)
Collaboration (1431)
Company closure (4)
Compensation (943)
Complete response letters (61)
COVID-19 (2961)
CRISPR (84)
C-suite (610)
Cystic fibrosis (140)
Data (4756)
Decentralized trials (2)
Denatured (63)
Depression (112)
Diabetes (459)
Diagnostics (7101)
Digital health (37)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (241)
Drug pricing (193)
Drug shortages (36)
Duchenne muscular dystrophy (205)
Earnings (99018)
Editorial (54)
Employer branding (25)
Employer resources (172)
Events (133239)
Executive appointments (996)
FDA (20843)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (6)
Frontotemporal dementia (16)
Funding (1292)
Gene editing (177)
Generative AI (52)
Gene therapy (560)
GLP-1 (1029)
Government (5391)
Grass and pollen (7)
Guidances (366)
Healthcare (20938)
HIV (48)
Huntington's disease (40)
IgA nephropathy (64)
Immunology and inflammation (248)
Immuno-oncology (21)
Indications (58)
Infectious disease (3210)
Inflammatory bowel disease (191)
Inflation Reduction Act (16)
Influenza (102)
Intellectual property (196)
Interviews (816)
IPO (17930)
IRA (59)
Job creations (5197)
Job search strategy (2866)
Kidney cancer (17)
Labor market (81)
Layoffs (643)
Leadership (36)
Legal (10148)
Liver cancer (92)
Longevity (13)
Lung cancer (585)
Lymphoma (269)
Machine learning (32)
Management (66)
Manufacturing (661)
MASH (145)
Medical device (14899)
Medtech (14924)
Mergers & acquisitions (22772)
Metabolic disorders (1177)
Multiple sclerosis (139)
NASH (23)
Neurodegenerative disease (234)
Neuropsychiatric disorders (63)
Neuroscience (2746)
NextGen: Class of 2025 (7687)
Non-profit (5096)
Now hiring (60)
Obesity (568)
Opinion (315)
Ovarian cancer (139)
Pain (170)
Pancreatic cancer (176)
Parkinson's disease (244)
Partnered (30)
Patents (427)
Patient recruitment (329)
Peanut (57)
People (66320)
Pharmaceutical (145)
Pharmacy benefit managers (28)
Phase I (23351)
Phase II (32849)
Phase III (24775)
Pipeline (2797)
Policy (300)
Postmarket research (3554)
Preclinical (10537)
Press Release (72)
Prostate cancer (204)
Psychedelics (52)
Radiopharmaceuticals (282)
Rare diseases (694)
Real estate (7422)
Recruiting (79)
Regulatory (28097)
Reports (65)
Research institute (2694)
Resumes & cover letters (651)
Rett syndrome (16)
RNA editing (15)
RSV (76)
Schizophrenia (139)
Series A (213)
Series B (159)
Service/supplier (30)
Sickle cell disease (81)
Special edition (26)
Spinal muscular atrophy (170)
Sponsored (41)
Startups (4319)
State (2)
Stomach cancer (17)
Supply chain (102)
Tariffs (96)
The Weekly (111)
Vaccines (1058)
Venture capital (67)
Weight loss (401)
Women's health (60)
Worklife (21)
Date
Today (137)
Last 7 days (743)
Last 30 days (2911)
Last 365 days (33552)
2025 (27579)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1282)
Alabama (80)
Alaska (7)
Arizona (307)
Arkansas (14)
Asia (51040)
Australia (8972)
California (9692)
Canada (2904)
China (932)
Colorado (409)
Connecticut (432)
Delaware (278)
Europe (117275)
Florida (1427)
Georgia (320)
Hawaii (3)
Idaho (67)
Illinois (822)
India (55)
Indiana (480)
Iowa (20)
Japan (331)
Kansas (126)
Kentucky (39)
Louisiana (22)
Maine (78)
Maryland (1299)
Massachusetts (7257)
Michigan (317)
Minnesota (575)
Mississippi (4)
Missouri (123)
Montana (33)
Nebraska (26)
Nevada (109)
New Hampshire (80)
New Jersey (2694)
New Mexico (32)
New York (2628)
North Carolina (1427)
North Dakota (10)
Northern California (4426)
Ohio (306)
Oklahoma (22)
Oregon (51)
Pennsylvania (2015)
Puerto Rico (20)
Rhode Island (46)
South America (1655)
South Carolina (50)
South Dakota (1)
Southern California (3699)
Tennessee (152)
Texas (1527)
United States (35731)
Utah (289)
Virginia (251)
Washington D.C. (84)
Washington State (833)
West Virginia (4)
Wisconsin (98)
Wyoming (1)
There are 862,043 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Manufacturing
Lilly Continues Manufacturing Push With $1.2B Puerto Rico Facility for GLP-1 Pill
The investment, which will expand Eli Lilly’s existing campus in Puerto Rico, is slated to create 100 new jobs, on top of around 1,000 construction-related roles.
October 30, 2025
·
2 min read
·
Tristan Manalac
CAR-T
Kyverna’s CAR T Therapy Sets ’New Efficacy Standard’ in Myasthenia Gravis, De-Risking Phase III Trials
With a 100% response rate in a Phase II study, KYV-101 sets a new efficacy bar in generalized myasthenia gravis, according to analysts at William Blair.
October 30, 2025
·
2 min read
·
Tristan Manalac
Regulatory
Life-Threatening Liver Toxicity Triggers FDA Freeze on Two Intellia Gene Therapy Studies
The clinical hold comes days after Intellia voluntarily paused enrollment and dosing in the same two studies.
October 30, 2025
·
2 min read
·
Tristan Manalac
Mergers & acquisitions
Novo Nordisk Seeks to Steal Metsera From Pfizer With $8.5B Offer
The Danish pharma was rumored to be a bidder in the process to acquire Metsera earlier this year, which Pfizer ultimately won with a $4.9 billion offer.
October 30, 2025
·
2 min read
·
Annalee Armstrong
Press Releases
Agios Reports Third Quarter 2025 Financial Results and Provides Business Update
October 30, 2025
·
10 min read
Press Releases
Evommune Announces Commencement of Initial Public Offering
October 30, 2025
·
3 min read
Press Releases
Merck & Co., Inc., Rahway, N.J., USA Announces Third-Quarter 2025 Financial Results
October 30, 2025
·
20 min read
Press Releases
Omnicell Announces Third Quarter 2025 Financial Results
October 30, 2025
·
20 min read
Press Releases
ProImmune Ltd Introduces ProVE® SL Self‑Loading MHC Class I Monomers to Improve T Cell Research Flexibility
October 30, 2025
·
2 min read
Press Releases
Bristol Myers Squibb Reports Third Quarter Financial Results for 2025
October 30, 2025
·
1 min read
1 of 86,205
Next
